241. Busch C., Machens A., Pichlmeier U. et al. Long-term outcome and quality of life after thymectomy for myasthenia gravis // Ann. Surg. – 1996. – V. 224. – № 2. – P. 225–232.
242. Busse F., Omidi L., Leichtle A. et al. Lead poisoning due to adulterated marijuana // N. Engl. J. Med. – 2008. – V. 358. – № 15. – P. 1641–1642.
243. Buter T., Aarsland D. Long-term prevalence of dementia in Parkinson’s disease // Neurodegenerative Dis. – 2007. – V. 4 (Suppl 1). – P. 119.
244. Carpenter B., Dave J. Disclosing a dementia diagnosis // Gerontologist. – 2004. – V. 44. – № 1. – P. 149–158.
245. Caroto A., Paolucci H. Depression after stroke // The behavioral and cognitive neurology of stroke / ed. Godefroy O. G., Bogousslavsky J. – Cambridge: University press, 2007. – P. 548–570.
246. Chabriat H., Bousser M.G. Vascular dementia // Eur. Neurol. – 2006. – V. 55. – № 2. – P. 61–69.
247. Coban A., Akman-Demir G., Ozsut H., Eraksoy M. Multiple sclerosis-like clinical and MRI findings in HIV positive – case // Neurologist. – 2007. – V. 13. – № 3. – P. 154–157.
248. Coelho D., Suormala T., Stucki M. et al. Gene identification for the cblD defect of vitamin B12 metabolism // N Engl J Med. – 2008. – V. 358. – № 14. – P. 1454–1464.
249. Consoli D., Di Carlo A., Inzitari D. et al. Subcortical ischaemic changes in young hypertensive patients: frequency, effect on cognitive performance and relationship with markers of endothelial and haemostatic activation // Eur J Neurol. – 2007. – V. 14. – № 11. – P. 222–1229.
250. Craiq D., Birks J. Galantamine for vascular cognitive impairment // Cochrane Database Syst Rev. – 2006. – V. 25. – № 1. – CD004746.
251. Cummings J. L., Mackell J., Kaufer D. Behavioral effects of current Alzheimers disease treatments // Alzheimers dementia. – 2008. – V. 4. – № 1. – P. 49–60.
252. Davison A. N., Dobbing J. Applied Neurochemistry. – Philadelphia: Davis, 1968. – 342 p.
253. Dubois B., Stachevsky A., Litvan I., Pillon B. The FAB: a frontal assessement battery at bedside // Neurology. – 2000. – V. 55 – № 5. – P. 1621–1626.
254. Dubois B., Feldman H. H., Jacova C. et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria // Lancet Neurol. – 2007. – V. 6. – № 8. – P. 734–746.
255. Duff K., Mold J., Roberts MM. Walking speed and global cognition: results from the OKLAHOMA study // Neuropsychol Dev. Cogn. B. Aging. Neuropsychol. Cogn. – 2007. – V. 18. – № 1. – P. 1–9.
256. Duran E., Chacon J. R. Parkinsonism probably induced by manganese // Rev Neurol. – 2001. – Vol. 33. – № 5. – P. 434–436.
257. Durga J., van Boxtel M. P., Schouten E. G. et al. Effect of 3-year folic acid supplementation on cognitive function in older adults // Lancet. – 2007. – V. 369. – P. 208–216.
258. Echeverria D., Woods J. S., Heyer N. J. et al. The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans // Neurotoxicol Teratol. – 2006. – V. 28. – № 1. – P. 39–48.
259. Eichenwald E. C., Stark A. R. Management and outcomes of very low birth weight // N Engl J Med. – 2008. – V. 358. – № 16. – P. 1700–1711.
260. Eide P. K. Intracranial pressure parameters in INPH patients treated with ventriculo-peritoneal shunts // Acta Neurochir (Wien). – 2006. – V. 148. – № 1. – P. 21–29.
261. Emre M., Aarsland D., Albanese A. Rivastigmine for dementia associated with Parkinsons disease // N. Engl. J. Med. – 2004. – V. 351. – № 24. – P. 2509–2518.
262. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis // Neurology. – 2002. – V. 59. – № 5. – P. 674–678.
263. Fielding J., Georgiou-Karistianis N., White O. The role of the basal ganglia in the control of automatic visuospatial attention // J. Int.Neuropsychol Soc. – 2006. – V. 12. – № 5. – P. 657–667.
264. Fiszer U. Does Parkinson’s disease have an immunological basis? The evidence and its therapeutic implications // BioDrugs.-2001. – V. 15. – № 6. – P. 351–355.
265. Folstein M., Folstein S. Mc Hugh R. Mini-mental state. A practical method for grading the cognitive state of patients for clinician // J. Psychiatr.Res. – 1975. – № 12. – P. 189–190.
